Search research articles
Contact Us
Filters
Showing results (11-20 of 134) with videos related to
Page
of 14
Sort By:
Cellular Immunology
|
September 1, 1986
Histamine inhibits interferon-gamma production via suppression of interleukin 2 synthesis
M Dohlsten, H O Sjögren, R Carlsson
Cellular Immunology
|
October 1, 1987
Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-gamma production
M Dohlsten, H O Sjögren, R Carlsson
Cellular Immunology
|
November 1, 1985
Histamine modulates the production of interferon-gamma and interleukin-2 by mitogen-activated human mononuclear blood cells
R Carlsson, M Dohlsten, H O Sjögren
Cancer Gene Therapy
|
November 4, 2000
Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor
O Björkdahl, M Dohlsten, H O Sjögren
Cellular Immunology
|
November 1, 1996
TCR alpha beta+ anti-tumor cytolytic T lymphocytes express NKR-P1 whilethe anti-tumor activity of TCR gamma delta+ T lymphocytes is not correlated to NKR-P1 expression
U Yrlid, E Petersson, M Dohlsten, et al.
Immunology
|
October 10, 1998
ICAM-1 costimulation induces IL-2 but inhibits IL-10 production in superantigen-activated human CD4+ T cells
T Labuda, J Wendt, G Hedlund, et al.
Cancer Immunology, Immunotherapy : CII
|
August 1, 1995
Enhanced and prolonged efficacy of superantigen-induced cytotoxic T lymphocyte activity by interleukin-2 in vivo
H Belfrage, M Dohlsten, G Hedlund, et al.
Immunology
|
February 1, 1997
Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivo
H Belfrage, M Dohlsten, G Hedlund, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 13, 2001
Identification of a CD28 response element in the CD40 ligand promoter
E Parra, T Mustelin, M Dohlsten, et al.
Cancer Immunology, Immunotherapy : CII
|
April 1, 1997
Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatment
H Belfrage, M Dohlsten, G Hedlund, et al.
Page
of 14
Search research articles
Search
Showing results (11-20 of 134) with videos related to
Sort By:
Page
of 14
Cellular Immunology
|
September 1, 1986
Histamine inhibits interferon-gamma production via suppression of interleukin 2 synthesis
M Dohlsten, H O Sjögren, R Carlsson
Cellular Immunology
|
October 1, 1987
Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-gamma production
M Dohlsten, H O Sjögren, R Carlsson
Cellular Immunology
|
November 1, 1985
Histamine modulates the production of interferon-gamma and interleukin-2 by mitogen-activated human mononuclear blood cells
R Carlsson, M Dohlsten, H O Sjögren
Cancer Gene Therapy
|
November 4, 2000
Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor
O Björkdahl, M Dohlsten, H O Sjögren
Cellular Immunology
|
November 1, 1996
TCR alpha beta+ anti-tumor cytolytic T lymphocytes express NKR-P1 whilethe anti-tumor activity of TCR gamma delta+ T lymphocytes is not correlated to NKR-P1 expression
U Yrlid, E Petersson, M Dohlsten, et al.
Immunology
|
October 10, 1998
ICAM-1 costimulation induces IL-2 but inhibits IL-10 production in superantigen-activated human CD4+ T cells
T Labuda, J Wendt, G Hedlund, et al.
Cancer Immunology, Immunotherapy : CII
|
August 1, 1995
Enhanced and prolonged efficacy of superantigen-induced cytotoxic T lymphocyte activity by interleukin-2 in vivo
H Belfrage, M Dohlsten, G Hedlund, et al.
Immunology
|
February 1, 1997
Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivo
H Belfrage, M Dohlsten, G Hedlund, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 13, 2001
Identification of a CD28 response element in the CD40 ligand promoter
E Parra, T Mustelin, M Dohlsten, et al.
Cancer Immunology, Immunotherapy : CII
|
April 1, 1997
Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatment
H Belfrage, M Dohlsten, G Hedlund, et al.
Page
of 14